The interaction between EEN and Abi-1, two MLL fusion partners, and synaptojanin and dynamin: Implications for leukaemogenesis

Leukemia

Volumn 14, Issue 4, 2000, Pages 594-601

  So, C W ^a   So, C K C ^a   Cheung, N ^a   Chew, S L ^a   Sham, M H ^a   Chan, L C ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Abi 1; EEN family; MLL; SH3 domain; Synaptojanin

Indexed keywords

DYNAMIN; PHOSPHATASE; SYNAPTOJANIN; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW; GENE; HUMAN; LEUKEMIA CELL LINE; LEUKEMOGENESIS; LEUKOCYTE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; YEAST;

EID: 0034119048     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2401692     Document Type: Article

References (72)

1. Ziemin-van der PS, McCabe NR, Gill HJ, Espinosa R III, Patel Y, Harden A, Rubinelli P, Smith SO, LeBeau MM, Rowley JD, Diaz MO. Identification of a gene, MLL, that spans the breakpoint in 11q23 translocations associated with human leukaemias. Proc Natl Acad Sci USA 1991; 88: 10735-10739.
2. Djabali M, Selleri L, Parry P, Bower M, Young BD, Evans GA. A trithorax-like gene is interrupted by chromosome 11q23 translocations in acute leukaemias. Nat Genet 1992; 2: 113-118.
3. Gu Y, Nakamura T, Alder H, Prasad R, Canaani O, Cimino G, Croce CM, Canaani E. The t(4;11) chromosome translocation of human acute leukaemias fuses the ALL-1 gene, related to Drosophila trithorax, to the AF-4 gene. Cell 1992; 71: 701-708.
4. Tkachuk DC, Kohler S, Cleary ML. Involvement of a homolog of Drosophila trithorax by 11q23 chromosomal translocations in acute leukaemias. Cell 1992; 71: 691-700.
5. Bernard OA, Berger R. Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations. Genes Chromosom Cancer 1995; 13: 75-85.
6. Sana V, Chaplin T, Gregorini A, Ayton P, Young BD The leukaemia-associated protein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins. Proc Natl Acad Sci USA 1995; 92: 9737-9741.
7. Aasland R, Gibson TJ, Stewart AF. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem Sci 1995; 20: 56-59.
8. Caldas C, Kim M-H, MacGregor A, Cain D, Aparicio S, Wiedemann LM. Isolation and characterization of a pufferfish MLL (mixed lineage leukaemia)-like gene (fMLL) reveals evolutionary conservation in vertebrate genes related to Drosophila trithorax. Oncogene 1998; 16: 3233-3241.
9. Hess JL, Yu BD, Li B, Hanson R, Korsmeyer SJ. Defects in yolk sac hematopoiesis in MLL-null embryos. Blood 1997; 90: 1799-1806.
10. Yu BD, Hess JL, Horning SE, Brown GAI, Korsmeyer SJ. Altered Hox expression and segmental identity in MLL-mutant mice. Nature 1995; 378: 505-508.
11. Kersey JH. Fifty years of studies of the biology and therapy of childhood leukaemia. Blood 1997; 90: 4243-4251.
12. Lavau C, Szilvassy SJ, Slany R, Cleary ML. Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL. EMBO J 1997; 16: 4226-4237.
13. Slany RK, Lavau C, Cleary ML The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX. Mol Cell Biol 1998; 18: 122-129.
14. Corral J, Lavenir I, Impey H, Warren AJ, Forster A, Larso TA, Bell S, McKenzie AN, King G, Rabbitts TH. An MLL-AF9 fusion gene made by homologous recombination causes acute leukaemia in chimeric mice: a method to create fusion oncogenes. Cell 1996; 85: 853-861.
15. Thirman MJ, Levitan DA, Kobayashi H, Simon MC, Rowley JD. Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute myeloid leukaemia. Proc Natl Acad Sci USA 1994; 91: 12110-12114.
16. Mitani K, Kanda Y, Ogawa S, Tanaka T, Inazawa J, Yazaki Y, Hirai H. Cloning of several species of MLL/MEN chimeric cDNAs in myeloid leukaemia with t(11;19)(q23;p13.1) translocation. Blood 1995; 85: 2017-2024.
17. Shilatifard A, Lane WS, Jackson KW, Conaway RC, Conaway JW. An RNA polymerase II elongation factor encoded by the human ELL gene. Science 1996; 271: 1873-1876.
18. Sobulo OM, Borrow J, Tomek R, Reshmi S, Harden A, Schlegelberger B, Housman D, Doggett NA, Rowley JD, Zeleznik-Le NJ. MLL is fused to CBF, a histone acetyltransferase, in therapy-related acute myeloid leukaemia with a t(11;16)(q23;p13.3). Proc Natl Acad Sci USA 1997; 94: 8732-8737.
19. Ida K, Kitabayashi I, Taki T, Taniwaki M, Noro K, Yamamoto M, Ohki M, Hayashi Y. Adenoviral E1A-associated protein p300 is involved in acute myeloid leukaemia with t(11;22)(q23;q13). Blood 1997; 90: 4699-4704.
20. Morrissey J, Tkachuk DC, Milatovich A, Francke U, Link M, Cleary ML. A serine/proline-rich protein is fused to HRX in t(4;11) acute leukaemias. Blood 1993; 81: 1124-1131.
21. Bernard OA, Hillion J, LeConiat M, Berger R. A new case of translocation t(6;11)(q21;q23) in a therapy-related acute myeloid leukaemia resulting in an MLL-AF6q21 fusion. Genes Chromosom Cancer 1998; 22: 221-224.
22. Nakamura T, Alder H, Gu Y, Prasad R, Canaani O, Kamada N, Gale RP, Lange B, Crist WM, Nowell PC, Croce CM, Canaani E. Genes on chromosomes 4, 9, and 19 involved in 11q23 abnormalities in acute leukaemia share sequence homology and/or common motifs. Proc Natl Acad Sci USA 1993; 90: 4631-4635.
23. Chaplin T, Ayton P, Bernard OA, Saha V, Della Valle V, Hillion J, Gregorini A, Lillington D, Berger R, Young BD. A novel class of zinc finger/leucine zipper genes identified from the molecular cloning of the t(10;11) translocation in acute leukaemia. Blood 1995; 85: 1435-1441.
24. Prasad R, Leshkowitz D, Gu Y, Alder H, Nakamura T, Saito H, Huebner K, Berger R, Croce CM, Canaani E. Leucine-zipper dimerization motif encoded by the AF17 gene fused to ALL-1 (MLL) in acute leukaemia. Proc Natl Acad Sci USA 1994; 91: 8107-8111.
25. Rubnitz JE, Morrissey J, Savage PA, Cleary ML. ENL, the gene fused with HRX in t(11;19) leukaemias, encodes a nuclear protein with transcriptional activation potential in lymphoid and myeloid cells. Blood 1994; 84: 1747-1752.
26. Borkhardt A, Repp R, Haas OA, Leis T, Harbott J, Kreuder J, Hammermann J, Henn T, Lampert F. Cloning and characterization of AFX, the gene that fuses to MLL in acute leukaemias with a t(X;11)(q13;q23). Oncogene 1997; 14: 195-202.
27. Prasad R, Gu Y, Alder H, Nakamura T, Canaani O, Saito H, Huebner K, Gale RP, Nowell PC, Kuriyama K, Miyazaki Y, Croce CM, Canaani E. Cloning of the ALL-1 fusion partner, the AF-6 gene, involved in acute myeloid leukaemias with the t(6;11) chromosome translocation. Cancer Res 1993; 53: 5624-5628.
28. Bernard OA, Mauchauffe M, Mecucci C, Van Den Berghe H, Berger R. A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to AF-4, AF-9 nor ENL. Oncogcne 1994; 9: 1039-1045.
29. So CW, Caldas C, Liu M-M, Chen S-J, Huang Q-H, Gu L-J, Sham MH, Wiedemann LM, Chan LC. EEN encodes for a member of a new family of proteins containing an Src homology 3 domain and is the third gene located on chromosome 19p13 that fuses to MLL in human leukaemia. Proc Natl Acad Sci USA 1997; 94: 2563-2568.
30. Taki T, Shibuya N, Taniwaki M, Hanada R, Morishita K, Bessho F, Yanagisawa M, Hayashi Y. ABI-1, a human homolog to mouse Ab1-interactor 1, fuses the MLL gene in acute myeloid leukaemia with t(10;11)(p11.2;q23). Blood 1998; 92: 1125-1130.
31. Giachino C, Lantelme E, Lanzetti L, Saccone S, Bella-Valle G, Migone N. A novel SH3-containing human gene family preferentially expressed in the central nervous system. Genomics 1997; 41: 427-434.
32. Sparks AB, Hoffman NG, McConnell SJ, Fowlkes DMF, Kay BK. Cloning of ligand targets: systematic isolation of SH3 domain-containing proteins. Nat Biotechnol 1996; 14: 741-744.
33. Ringstad N, Nemoto Y, De Camilli P. The SH3p4/SH3p8/SH3p13 protein family: binding partners for synaptojanin and dynamin via a GrB2-like Src homology 3 domain. Proc Natl Acad Sci USA 1997; 94: 8569-8574.
34. Lowenstein EJ, Daly RJ, Batzer AG, Li W, Margolis B, Lammers R, Ullrich A, Skolnik EY, Bar-Sagi D, Schlessinger J. The SH2 and SH3 domain-containing protein GRB2 links receptor tyrosine kinases to ras signaling. Cell 1992; 70: 431-442.
35. Clark SG, Stern MJ, Horvitz HR. C. elegans cell-signalling gene sem-5 encodes a protein with SH2 and SH3 domains. Nature 1992; 356: 140-344.
36. Perkins LA, Larsen I, Perrimon N. Corkscrew encodes a putative protein tyrosine phosphatase that functions to transduce the terminal signal from the receptor tyrosine kinase torso. Cell 1992; 70: 225-236.
37. Pawson T. Protein modules and signalling networks. Nature 1995; 373: 573-580.
38. McPherson PS, Czernik AJ, Chilcote TJ, Onofri F, Benfenati F, Greengard P, Schlessinger J, de Camilli P. Interaction of GrB2 via its Src homology 3 domains with synaptic proteins including synapsin I. Proc Natl Acad Sci USA 1994; 91: 6486-6490.
39. McPherson PS, Takei K, Schmid SL, De Camilli P. p145, a major GrB2-binding protein in brain, is co-localized with dynamin in nerve terminals where it undergoes activity-dependent dephosphorylation. J Biol Chem 1994; 269: 30132-30139.
40. McPherson PS, Garcia EP, Slepnev VI, David C, Zhang X, Grabs D, Sossin WS, Bauerfeind R, Nemoto Y, De-Camilli P. A presynaptic inositol-5-phosphatase. Nature 1996; 379: 353-357.
41. Herskovits JS, Shpetner HS, Burgess CC, Vallee RB. Microtubules and Src homology 3 domains stimulate the dynamin GTPase via its C-terminal domain. Proc Natl Acad Sci USA 1993; 90: 11468-11472.
42. Urrutia R, Henley JR, Cook T, McNiven MA. The dynamins: redundnat or distinct functions for an expanding family of related GTPases? Proc Natl Acad Sci USA 1997; 94: 377-384.
43. Obar RA, Collins CA, Hammarback JA, Shpetner HS, Vallee RB. Molecular cloning of the microtubule-associated mechanochemical enzyme dynamin reveals homology with a new family of GTP-binding proteins. Nature 1990; 347: 256-261.
44. Chen MS, Obar RA, Schroeder CC, Austin TW, Poodry CA, Wadsworth SC, Vallee RB. Multiple forms of dynamin are encoded by shibire, a Drosophila gene involved in endocytosis. Nature 1991; 351: 583-586.
45. Ramjaun AR, McPherson PS. Tissue-specific alternative splicing generates two synaptojanin isoforms with differential membrane binding properties. J Biol Chem 1996; 271: 24856-24861
46. Haffner C, Takei K, Chen H, Ringstad N, Hudson A, Butler MH, Salcini AE, Di Fiore PP, DeCamilli P. Synaptojanin 1: localization on coated endocytic intermediates in nerve terminals and interaction of its 170 kDa isoform with Eps15. FEBS Lett 1997; 419: 175-180.
47. Ausubel FM, Brent R, Kingston R, Moore DD, Seidman JG, Smith JA, Struhl K. Current protocols in molecular biology, 3rd edn. John Wiley & Sons Inc: New York, USA, 1997.
48. Mayer BJ, Eck MJ. SH3 domains. Minding your p's and q's. Curr Biol 1995; 5: 364-367.
49. Feng S, Chen JK, Yu H, Simon JA, Schreiber SL. Two binding orientations for peptides to the Src SH3 domain: development of a general model tor SH3-ligand interactions. Science 1994; 266: 1241-1247.
50. Desbois C, Rousset R, Bantignies F, Jalinot P. Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax oncoprotein. Science 1996; 273: 951-953.
51. Jin DY, Jeang KT. HTLV-I Tax self-association in optimal transactivation function. Nucleic Acids Res 1997; 25: 379-387.
52. Gout I, Dhand R, Hiles ID, Fry MJ, Panayotou G, Das P, Truong O, Totty NF, Hsuan J, Booker GW, Campbell ID, Waterfield MD. The GTPase dynamin binds to and is activated by a subset of SH3 domains. Cell 1993; 75: 25-36.
53. Erneux C, Govaerts C, Communi D, Pesesse X. The diversity and possible functions of the inositol polyphosphate 5-phosphatases. Biochim Biophys Acta 1998; 1436: 185-199.
54. Floyd S, De Camilli P. Endocytosis proteins and cancer: a potential link? Trends Cell Biol 1998; 8: 299-101.
55. Ringerike T, Stang E, Johannessen LE, Sandnes D, Levy FO, Madshus IH. High-affinity binding of epidermal growth factor (EGF) to EGF receptor is disrupted by overexpression of mutant dynamin (K44A). J Biol Chem 1998; 27: 16659-16642.
56. Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G, The 145-kDa protein induced to associate with Shc by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphate 5-phosphatase. Proc. Natl Acad Sci USA 1996; 93: 1689-1693.
57. Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold R, Rohrschneider LR. p150, Ship. a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev 1996; 10: 1084-1095.
58. Woscholski R, Finan PM, Radley E, Totty NF, Sterling AE, Hsuan JJ, Waterfield MD, Parker PJ. Synaptojanin is the major constitutively active phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase in rodent brain. J Biol Chem 1997; 272: 9625-9628.
59. Stephens LR, Jackson TR, Hawkins PT. Agonist-stimulated synthesis of phosphatidylinositol (3,4,5)-trisphosphate: a new intracellular signalling system? Biochim Biophys Acta 1993; 1179: 27-75.
60. Downward J. Lipid-regulated kinases: some common themes at last. Science 1998; 279: 673-674.
61. Helgason CD, Damen JE, Rosten P, Grewal R, Sorensen P, Chappel SM, Borowski A, Jirik F, Krystal G, Humphries RK. Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. Genes Dev 1998; 12: 1610-1620.
62. Liu L, Damen JE, Hughes MR, Babic I, Jirik FR, Krystal G. The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with Shc, and its induction of apoptosis. J Biol Chem 1997; 272: 8983-8988.
63. Yao R, Cooper GM. Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor. Science 1995; 267: 2003-2006.
64. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, MeCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947.
65. Furnari FB, Huang HJ, Cavenee WK. The phosphoinositol phosphatase activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res 1998; 58: 5002-5008.
66. Furnari FB, Lin H, Huang HS, Cavenee WK. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc Natl Acad Sci USA 1997; 94: 12479-12484.
67. Maehama T, Dixon JE. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J Biol Chem 1998; 273: 13375-13378.
68. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, Wigler MH, Downes CP, Tonks NK. The lipid phosphatase activity of PTEN is critical for its tumor supressor function. Proc Natl Acad Sci USA 1998; 95: 13513-13518.
69. Rogaia D, Grignani F, Carbone R, Riganelli D, LoCoco F, Nakamura T, Croce CM, Di Fiore PP, Pelicci PG. The localization of the HRX/ALL1 protein to specific nuclear subdomains is altered by fusion with its Eps15 translocation partner. Cancer Res 1997; 57: 799-802.
70. Shi Y, Alin K, Goff SP. Ab1-interactor-1, a novel SH3 protein binding to the carboxy-terminal portion of the Ab1 protein, suppresses v-abl transforming activity. Genes Dev 1995; 9: 2583-2597.
71. Biesova Z, Piccoli C, Wong WT. Isolation and characterization of e3B1, an eps8 binding protein that regulates cell growth. Oncogene 1997; 14: 233-241.
72. Kops GJ, de Ruiter ND, De Vries-Smits AM, Powell DR, Bos JL, Burgering BM. Direct control of the Forkhead transcription factor AFX by protein kinase B. Nature 1999; 398: 630-634.